188 related articles for article (PubMed ID: 34912705)
1. Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines.
Lin LH; Chou CH; Cheng HW; Chang KW; Liu CJ
Front Oncol; 2021; 11():741626. PubMed ID: 34912705
[TBL] [Abstract][Full Text] [Related]
2. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
[TBL] [Abstract][Full Text] [Related]
3. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma.
Lin LH; Chang KW; Cheng HW; Liu CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
[TBL] [Abstract][Full Text] [Related]
5. Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits.
Patel K; Bhat FA; Patil S; Routray S; Mohanty N; Nair B; Sidransky D; Ganesh MS; Ray JG; Gowda H; Chatterjee A
Front Oncol; 2021; 11():660696. PubMed ID: 34136393
[TBL] [Abstract][Full Text] [Related]
6. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.
India Project Team of the International Cancer Genome Consortium
Nat Commun; 2013; 4():2873. PubMed ID: 24292195
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract][Full Text] [Related]
10. Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma.
Rodney AR; Skidmore ZL; Grenier JK; Griffith OL; Miller AD; Chu S; Ahmed F; Bryan JN; Peralta S; Warren WC
Front Vet Sci; 2023; 10():1079019. PubMed ID: 37266381
[TBL] [Abstract][Full Text] [Related]
11. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
12. Mutation detection in saliva from oral cancer patients.
Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
[TBL] [Abstract][Full Text] [Related]
13. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.
Nakagaki T; Tamura M; Kobashi K; Koyama R; Fukushima H; Ohashi T; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
Oncotarget; 2017 Aug; 8(35):59113-59122. PubMed ID: 28938622
[TBL] [Abstract][Full Text] [Related]
14. Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort.
Mangalaparthi KK; Patel K; Khan AA; Manoharan M; Karunakaran C; Murugan S; Gupta R; Gupta R; Khanna-Gupta A; Chaudhuri A; Kumar P; Nair B; Kumar RV; Prasad TSK; Chatterjee A; Pandey A; Gowda H
Front Oncol; 2020; 10():1457. PubMed ID: 32974170
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma.
Cacheux W; Dangles-Marie V; Rouleau E; Lazartigues J; Girard E; Briaux A; Mariani P; Richon S; Vacher S; Buecher B; Richard-Molard M; Jeannot E; Servant N; Farkhondeh F; Mariani O; Rio-Frio T; Roman-Roman S; Mitry E; Bieche I; Lièvre A
Oncotarget; 2018 Jan; 9(1):464-476. PubMed ID: 29416628
[TBL] [Abstract][Full Text] [Related]
16. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
[TBL] [Abstract][Full Text] [Related]
17. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract][Full Text] [Related]
18. Absence of the frequently reported PIK3CA, CASP8, and NOTCH1 mutations in South Indian oral cancers.
Arunkumar G; Murugan AK; Nagarajan M; Ajay C; Rajaraman R; Munirajan AK
Oral Dis; 2017 Jul; 23(5):669-673. PubMed ID: 28181739
[TBL] [Abstract][Full Text] [Related]
19. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.
Pickering CR; Zhang J; Yoo SY; Bengtsson L; Moorthy S; Neskey DM; Zhao M; Ortega Alves MV; Chang K; Drummond J; Cortez E; Xie TX; Zhang D; Chung W; Issa JP; Zweidler-McKay PA; Wu X; El-Naggar AK; Weinstein JN; Wang J; Muzny DM; Gibbs RA; Wheeler DA; Myers JN; Frederick MJ
Cancer Discov; 2013 Jul; 3(7):770-81. PubMed ID: 23619168
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.
Kim JY; Lee E; Park K; Park WY; Jung HH; Ahn JS; Im YH; Park YH
Oncotarget; 2017 Apr; 8(17):27997-28007. PubMed ID: 28427202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
